comparemela.com

Latest Breaking News On - அல்லாத ஆல்கஹால் கொழுப்பு கல்லீரல் நோய் - Page 11 : comparemela.com

HKUMed discovers a novel mediator of liver fibrosis and its underlying mechanism that can be a new therapeutic target

Date Time Share HKUMed discovers a novel mediator of liver fibrosis and its underlying mechanism that can be a new therapeutic target HKUMed discovers a novel mediator of liver fibrosis and its underlying mechanism that can be a new therapeutic target. The research was led by Dr Ruby Hoo Lai-chong (second from left), Assistant Professor, Department of Pharmacology and Pharmacy, HKUMed and Co-investigator of State Key Laboratory of Pharmaceutical Biotechnology, HKU. Dr Wu Xiaoping (second from right), post-doctoral fellow, Department of Pharmacology and Pharmacy, HKUMed is the first author. Other research team members include: Ms Zong Jiuyu (left) and Ms Zhang Zixuan (right), postgraduate student, Department of Pharmacology and Pharmacy, HKUMed.

Mouse model closely reproduces human fatty liver disease

Date Time Mouse model closely reproduces human fatty liver disease A team at Baylor College of Medicine and other institutions has developed a novel mouse model that reproduces many key features of human non-alcoholic fatty liver disease (NAFLD), a little-understood condition that significantly increases the risk of inflammation, fibrosis and liver cancer and ultimately requires liver transplant. With this model, researchers have an opportunity to advance the understanding and treatment of this serious condition for which there is no effective therapy. The study appeared in JHEP Reports. “NAFLD has been difficult to study since we had no good animal model,” said corresponding author Dr. Karl-Dimiter Bissig, who was at Baylor during the development of this project and is now at Duke University.

ENDRA Life Sciences Inc : ENDRA Life Sciences to Present at AIUM Annual Integrative Ultrasound Meeting

ENDRA Life Sciences Inc.: ENDRA Life Sciences to Present at AIUM Annual Integrative Ultrasound Meeting ANN ARBOR, MI / ACCESSWIRE / April 8, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ®), today announced that the Company s Chief Technology Officer will be making a presentation at the American Institute of Ultrasound in Medicine (AIUM) Annual Integrative Ultrasound Meeting on April 14 at 11:45 am ET. The presentation will feature an overview of ENDRA s TAEUS technology and its initial clinical application for the measurement of liver fat. ENDRA will also be showcasing its TAEUS ® liver system in its virtual booth April 11 through April 25.

ENDRA Life Sciences to Present at AIUM Annual Integrative Ultrasound Meeting

ENDRA Life Sciences to Present at AIUM Annual Integrative Ultrasound Meeting
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.